Literature DB >> 26567910

Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.

J David Spence1, Bradley L Urquhart2, Heejung Bang3.   

Abstract

BACKGROUND: Cardiovascular risk and plasma total homocysteine (tHcy) are high in patients with renal failure. High tHcy may account for a substantial part of the increased risk. We assessed mediation by tHcy of the association of estimated glomerular filtration rate (eGFR CKD/EPI) with carotid total plaque area (TPA) and carotid stenosis.
METHODS: TPA and carotid stenosis were measured by ultrasound. Multiple linear regression was used to assess the effects of eGFR and/or tHcy after adjustment for age, sex, systolic blood pressure (SBP), smoking, LDL, HDL and weight.
RESULTS: Complete data were available for 1967 patients. eGFR decreased, and TPA and total stenosis increased linearly with age. After adjustment [age, sex, SBP, smoking (in pack years), low-density lipoprotein (LDL), high-density lipoprotein (HDL) and weight], eGFR and tHcy were independently associated with TPA (P < 0.01), but when both were added to the model, their significance was attenuated (P = 0.06 for eGFR, 0.03 for tHcy). Mediation analysis showed that tHcy seems to contribute to a significant mediation of the association of eGFR with TPA but not stenosis; after adjustment for the set of risk factors listed above, tHcy still demonstrated significant mediation on TPA (P = 0.03), but not on stenosis (P = 0.16).
CONCLUSIONS: tHcy accounts for a significant part, but not all of the effect of renal impairment on atherosclerosis. Other uremic toxins including metabolic products of the intestinal microbiome may explain residual effects of renal failure on atherosclerosis. Therapeutic approaches arising from that hypothesis are discussed.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  ADMA; TMAO; cardiovascular risk; indoles; intestinal microbiome

Mesh:

Substances:

Year:  2015        PMID: 26567910      PMCID: PMC4876968          DOI: 10.1093/ndt/gfv380

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  58 in total

1.  Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.

Authors:  J David Spence; Meir J Stampfer
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

2.  B-vitamin therapy for diabetic nephropathy.

Authors:  Sarika Kadam; Satyarth Kulshrestha; Sundararaman Swaminathan
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

3.  The cardiovascular effect of the uremic solute indole-3 acetic acid.

Authors:  Laetitia Dou; Marion Sallée; Claire Cerini; Stéphane Poitevin; Bertrand Gondouin; Noemie Jourde-Chiche; Karim Fallague; Philippe Brunet; Raymond Calaf; Bertrand Dussol; Bernard Mallet; Françoise Dignat-George; Stephane Burtey
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

Review 4.  Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.

Authors:  Christopher S Wilcox
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

5.  Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Authors:  Gerald Schulman; Tomas Berl; Gerald J Beck; Giuseppe Remuzzi; Eberhard Ritz; Kiyoshi Arita; Akira Kato; Miho Shimizu
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

6.  Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study.

Authors:  Ellisiv B Mathiesen; Stein Harald Johnsen; Tom Wilsgaard; Kaare H Bønaa; Maja-Lisa Løchen; Inger Njølstad
Journal:  Stroke       Date:  2011-02-10       Impact factor: 7.914

7.  Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.

Authors:  W H Wilson Tang; Zeneng Wang; David J Kennedy; Yuping Wu; Jennifer A Buffa; Brendan Agatisa-Boyle; Xinmin S Li; Bruce S Levison; Stanley L Hazen
Journal:  Circ Res       Date:  2014-11-05       Impact factor: 17.367

8.  Low hydrogen sulphide and chronic kidney disease: a dangerous liaison.

Authors:  Alessandra F Perna; Diego Ingrosso
Journal:  Nephrol Dial Transplant       Date:  2012-02       Impact factor: 5.992

Review 9.  Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.

Authors:  Cristiane Moraes; Denis Fouque; Ana Claudia F Amaral; Denise Mafra
Journal:  J Ren Nutr       Date:  2015-07-31       Impact factor: 3.655

10.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Authors:  Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Nature       Date:  2011-04-07       Impact factor: 49.962

View more
  20 in total

1.  Homocysteine and chronic kidney disease: an ongoing narrative.

Authors:  Alessandra F Perna; Diego Ingrosso
Journal:  J Nephrol       Date:  2019-06-21       Impact factor: 3.902

2.  Influence of renal function on the association between homocysteine level and risk of ischemic stroke.

Authors:  Yao Cheng; Fan-Zhen Kong; Xiao-Feng Dong; Qin-Rong Xu; Qian Gui; Wei Wang; Hong-Xuan Feng; Wei-Feng Luo; Zong-En Gao; Guan-Hui Wu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

3.  The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort.

Authors:  Eytan Cohen; Ili Margalit; Tzippy Shochat; Elad Goldberg; Ilan Krause
Journal:  J Nephrol       Date:  2019-06-05       Impact factor: 3.902

Review 4.  Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences.

Authors:  J David Spence; Bradley L Urquhart
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-01       Impact factor: 6.030

5.  Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation.

Authors:  Ki-Woong Nam; Chi Kyung Kim; Sungwook Yu; Kyungmi Oh; Jong-Won Chung; Oh Young Bang; Gyeong-Moon Kim; Jin-Man Jung; Tae-Jin Song; Yong-Jae Kim; Bum Joon Kim; Sung Hyuk Heo; Kwang-Yeol Park; Jeong-Min Kim; Jong-Ho Park; Jay Chol Choi; Man-Seok Park; Joon-Tae Kim; Kang-Ho Choi; Yang Ha Hwang; Woo-Keun Seo
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

6.  High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.

Authors:  Zengchun Ye; Qunzi Zhang; Yan Li; Cheng Wang; Jun Zhang; Xinxin Ma; Hui Peng; Tanqi Lou
Journal:  Nutrients       Date:  2016-10-20       Impact factor: 5.717

7.  Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism.

Authors:  Lin Chen; Tomoaki Ishigami; Rie Nakashima-Sasaki; Tabito Kino; Hiroshi Doi; Shintaro Minegishi; Satoshi Umemura
Journal:  EBioMedicine       Date:  2016-10-20       Impact factor: 8.143

8.  Intestinal Microbiome and Atherosclerosis - Authors' Reply.

Authors:  Lin Chen; Tomoaki Ishigami
Journal:  EBioMedicine       Date:  2016-10-27       Impact factor: 8.143

9.  Intestinal Microbiome and Atherosclerosis.

Authors:  J David Spence
Journal:  EBioMedicine       Date:  2016-10-26       Impact factor: 8.143

Review 10.  Recent advances in pathogenesis, assessment, and treatment of atherosclerosis.

Authors:  J David Spence
Journal:  F1000Res       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.